EurekAlert!14d
Beyond the cure: Navigating hepatocellular risk and surveillance after hepatitis C eradication in the direct-acting antiviral era
Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...
Mirage News13d
Hep C Cure: Managing Liver Cancer Risk Post-Treatment
Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular ...
News-Medical.Net on MSN13d
Review explores the underlying mechanisms of hepatocarcinogenesis post-HCV eradication
Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing ...
AlphaGalileo16d
Immune Subtyping and NK Cell Targeting: A New Frontier for Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, accounts for about 75–85% of all liver cancer cases. Immune checkpoint ...